Vanguard Global Advisers
COCH icon

Vanguard Global Advisers’s Envoy Medical COCH Stock Holding History

Vanguard Global Advisers’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Hold
3,788
– – ﹤0.01% 3589
2026
Q1 		$2.52K Buy
+3,788
New +$2.58K ﹤0.01% 3605

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Vanguard Global Advisers's COCH Position: Q2 2026 in Review

Vanguard Global Advisers held its Envoy Medical (COCH) position steady in Q2 2026 at 3,788 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

Vanguard Global Advisers first reported a position in COCH in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Vanguard Global Advisers held 3,788 shares of Envoy Medical worth $3K as of Q2 2026.
  • Vanguard Global Advisers left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3589 holding.
  • Vanguard Global Advisers first reported a position in Envoy Medical in Q1 2026 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.